Page last updated: 2024-10-29

iohexol and Cardiac Hypertrophy

iohexol has been researched along with Cardiac Hypertrophy in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Savchenko, AP1
PetrovskiÄ­, PF1
Geppe, ES1
KlembovskiÄ­, AA1

Other Studies

1 other study available for iohexol and Cardiac Hypertrophy

ArticleYear
[Effect of non-ionic roentgenocontrast preparation Omnipaque-350 on central hemodynamics and myocardial contraction].
    Kardiologiia, 1984, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Angiocardiography; Cardiomegaly; Child; Contrast Media; Coronary Disease; Female;

1984